Pre-Market Stock News (September 13, 2007)
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
(AINV) Apollo Investment priced a 13 million share secondary at $20.00.
(ALU) Alcatel-Lucent lowered full year revenue guidance.
(ANPI) Angiotech Pharma said it received a favorable patent decision from New Zealand’s Intellectual Property Office.
(BLTI) BIOLASE Technology has been granted a new U.S. patent covering its oral care technologies for a teeth cleaning and whitening system for toothbrush with electromagnetic and photosensitive agents.
(BRCM) Broadcom: U.S. Appeals Court denied Qualcomm’s request to stay ITC order.
(BRLC) Syntax-Brillian traded down over 20% after earnings, lowered guidance, and CFO leaving.
(DKS) Dicks Sporting Goods announced a 2 for 1 stock split.
(ECA) EnCana is selling its Brazil offshore exploration concessions for $165 million.
(ISIS) ISIS Pharma entered a broad collaboration with Ortho-McNeil for discovery, development and commercialization of antisense drugs to treat metabolic diseases, including Type 2 diabetes.
(MCD) McDonald’s boosted its dividend by 50% and promised to continue returning cash to holders.
(MMS) MAXIMUS received a Medicare Fraud pact from New York Life.
(MSFT) Microsoft increased its dividend, but only by 10% to $0.11 per quarter.
(SIRI) SIRIUS trading up another 1% pre-market on merger approval for XM hopes.
(SPI) Spectrum Pharma said the FDA accepted its ISO-Vorin new drug application amendment.
(TASR) Taser announced two follow-on orders for its electronic control devices.
(TGT) Target said it is reviewing its ownership of its credit card receivables.
Jon C. Ogg
September 13, 2007
Contact [email protected] for any questions or corrections.

